Smartleaf Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.1K | Sell |
200
-206
| -51% | -$25.8K | ﹤0.01% | 1459 |
|
|
2025
Q1 | $45.9K | Sell |
406
-132
| -25% | -$14.9K | ﹤0.01% | 1193 |
|
|
2024
Q4 | $73.7K | Buy |
538
+146
| +37% | +$20K | 0.01% | 989 |
|
|
2024
Q3 | $45.1K | Buy |
392
+251
| +178% | +$28.9K | 0.01% | 956 |
|
|
2024
Q2 | $18.9K | Buy |
141
+94
| +200% | +$12.6K | ﹤0.01% | 1058 |
|
|
2024
Q1 | $6.48K | Buy |
47
+44
| +1,467% | +$6.07K | ﹤0.01% | 1135 |
|
|
2023
Q4 | $0 | Buy |
+3
| New | – | ﹤0.01% | 1201 |
|